UY38899A - DIACILGLYCEROL ACILTRANSFERASE 2 INHIBITOR - Google Patents
DIACILGLYCEROL ACILTRANSFERASE 2 INHIBITORInfo
- Publication number
- UY38899A UY38899A UY0001038899A UY38899A UY38899A UY 38899 A UY38899 A UY 38899A UY 0001038899 A UY0001038899 A UY 0001038899A UY 38899 A UY38899 A UY 38899A UY 38899 A UY38899 A UY 38899A
- Authority
- UY
- Uruguay
- Prior art keywords
- diacilglycerol
- aciltransferase
- inhibitor
- inhibitors
- dgat2
- Prior art date
Links
Abstract
En la presente se describen compuestos de la Fórmula (I) (I) en donde R1, R2, R3, R4, R5, R6, R7, R8 y R9 se definen en la presente, su uso como inhibidores de diacilglicerol aciltransferasa 2 (DGAT2), composiciones farmacéuticas que contienen dichos inhibidores y el uso de dichos inhibidores para tratar, por ejemplo, NASH.Described herein are compounds of Formula (I) (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, and R9 are defined herein, their use as diacylglycerol acyltransferase 2 (DGAT2) inhibitors ), pharmaceutical compositions containing said inhibitors and the use of said inhibitors to treat, for example, NASH.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201963074123P | 2019-09-03 | 2019-09-03 | |
| US201962911094P | 2019-10-04 | 2019-10-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY38899A true UY38899A (en) | 2021-04-30 |
Family
ID=76193366
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001038899A UY38899A (en) | 2019-09-03 | 2020-09-30 | DIACILGLYCEROL ACILTRANSFERASE 2 INHIBITOR |
Country Status (1)
| Country | Link |
|---|---|
| UY (1) | UY38899A (en) |
-
2020
- 2020-09-30 UY UY0001038899A patent/UY38899A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY38076A (en) | TETRAHYDROQUINAZOLINE DERIVATIVES USEFUL AS ANTI-CANCER AGENTS | |
| CL2019001711A1 (en) | Compositions and methods for inhibiting the action of arginase. | |
| UY37795A (en) | SULFONILUREAS AND SULFONILTIOUREAS USEFUL AS INHIBITORS OF NLRP3 | |
| CU20190003A7 (en) | DIACILGLICEROL ACILTRANSFERASE 2 INHIBITORS | |
| BR112019002610A2 (en) | cdk2 / 4/6 inhibitor pyridopyrimidinones | |
| CO2019003482A2 (en) | Compounds derived from cyclobutane or azetidine 1,3 substituted as hematopoietic prostaglandin d synthase inhibitors | |
| CL2022000835A1 (en) | Diacylglycerol acyltransferase 2 inhibitor | |
| BR112017003658A2 (en) | compound, mixture, methods for treating a disease and for inhibiting a glycosidase; and, pharmaceutical composition. | |
| BR112018003026A2 (en) | compositions comprising a pi3k inhibitor and an hdac inhibitor | |
| PE20151981A1 (en) | ZESTE APPROVAL INHIBITOR PONTENCER | |
| BR112021022758A2 (en) | Substituted 1-oxo-isoindoline-5-carboxamide compounds, their compositions and methods of treatment therewith | |
| BR112018070123A2 (en) | oxiesterós and methods of use thereof | |
| CL2017002856A1 (en) | Thioether compounds as nitrification inhibitors | |
| CO2019002692A2 (en) | New derivatives of isoxazolyl ether as pam of gaba to alpha5. | |
| CL2021001461A1 (en) | trex1 modulators | |
| CO2019004978A2 (en) | Therapeutic compounds and methods to use them | |
| CO2021001219A2 (en) | Substituted benzimidazoles as pad4 inhibitors | |
| CO2018010787A2 (en) | Griseofulvin compound | |
| AR125457A2 (en) | DUAL MAGL AND FAAH INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITION | |
| CL2020002217A1 (en) | Use of alkoxypyrazoles as nitrification inhibitors | |
| HN2011000404A (en) | ENFUMAFUNGINA AND COMPOSITION DERIVATIVES UNDERSTANDING THE SAME | |
| BR112019021323A2 (en) | HETEROCYCLIC INHIBITORS OF LYSINE BIOSYNTHESIS THROUGH THE DIAMINOPIMELATE ROUTE | |
| CO2022010011A2 (en) | Novel amino aryl derivative useful as diacylglycerol acyltransferase 2 inhibitor and use thereof | |
| UY38899A (en) | DIACILGLYCEROL ACILTRANSFERASE 2 INHIBITOR | |
| MX2020004842A (en) | Anti-infective heterocyclic compounds and uses thereof. |